400 healthcare workers from Kenya’s coastal counties of Mombasa and Kilifi are wanted for coronavirus vaccine trials.
The vaccine trial which is being tested by Oxford University in UK, is also expected to begin towards the end of this week and will be carried out at Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme which is based in Kilifi county.
The initiative which is funded by the London based research charitable foundation Wellcome Trust through Oxford University will take a period of 2 years.
The coronavirus vaccine trials will be carried out at Kenya Medical Research Institute Kilifi centre. However, trial protocol shows that additional centres could be opened in case there’s more need.
World Health Organisation’s trial registration number PACTR202005681895696 will determine if a new coronavirus vaccine gives protection in adults in Kenya.
The protocol said whilst there are several biotech companies developing coronavirus vaccine, but none of them are in Africa and there’s no vaccine trials currently taking place across Africa.
According to the trial protocol, the performance in the vaccine from research in other citizens might not be generalized to Kenya and other countries in Africa.
The try out will assess the safety and protection of the vaccine known as ChAdOx1 nCoV-19 among 400 adults aged more than 18 years.
The tests will be held in Kenya’s coastal counties of Mombasa and Kilifi, where the highest number of covid-19 positive cases have been recorded, according to Standard Media.
- Coronavirus Vaccine Shows Promising Results In Several Human Trials
- Strong Strains Of Cannabis Could Help Prevent And Treat Coronavirus – Scientists
- 3 African Countries Chosen To Test World’s 1st Malaria Vaccine
Please use the button below to contribute to Newslex Point, Inc. using a credit card or via PayPal.